We are COMPASS Pathways, a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. Our first clinical development programme is researching investigational COMP360 psilocybin treatment for patients with treatment-resistant depression. 

We want to transform the patient experience in mental health care. 

WPSS.bio

Vivo Capital

Logos Capital

Aisling Capital

Armistice Capital

Soleus Capital

Surveyor Capital

TCG Crossover

Paradigm BioCapital Advisors

PFM Health Sciences

RA Capital Management

Principia SGR

Camden Partners

Founders Fund

McQuade Center for Strategic Research and Development

Able Partners

ATAI Life Sciences

Skyviews Life Science

Perceptive Advisors

Justin Mateen

Compass Pathways

Tryp Therapeutics is a company focused on developing transformative medicines for the treatment of neuropsychiatric and other disorders.

Tryp Therapeutics

Nue Life is a mental health care company dedicated to developing innovative treatments for mental health conditions, including depression.

Nue Life

Clairvoyant Therapeutics is a company specializing in the development of novel therapies for mental health disorders, including depression.

Clairvoyant Therapeutics

Sage Therapeutics is a biopharmaceutical company focused on the development of novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.

Sage Therapeutics

Axsome is a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, including depression.

Axsome

Compass Pathways is a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health. The company focuses on the development of psilocybin therapy through late-stage clinical trials, aiming to create a new standard in the treatment of mental health conditions such as treatment-resistant depression.

news_impact_assignment_basic

key_people

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

merger_acquisitions

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	May 11, 2024 9:54 AM	9403816e
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general	May 11, 2024 11:15 AM	9386b90f
company summary	general
signals	general
crunchbase trigger	general
crunchbase profile	general
li profile	general	May 11, 2024 9:54 AM	c0bba339
translate crunchbase fundingrounds	general
peers	general
news basic	general	May 11, 2024 9:54 AM	338844b0
bundesanzeiger	filings
merger acquisitions	company_analysis
financials download nd	financials
private financials	financials

COM:COMPASSPATHWAYS

Compass Pathways